Enlivex Therapeutics Ltd. (ENLV)
NASDAQ: ENLV · Real-Time Price · USD
0.976
-0.054 (-5.24%)
At close: Nov 20, 2024, 4:00 PM
0.980
+0.004 (0.42%)
Pre-market: Nov 21, 2024, 7:01 AM EST
Enlivex Therapeutics Employees
Enlivex Therapeutics had 71 employees as of December 31, 2021. The number of employees increased by 21 or 42.00% compared to the previous year.
Employees
71
Change (1Y)
21
Growth (1Y)
42.00%
Revenue / Employee
n/a
Profits / Employee
-$314,000
Market Cap
20.89M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2021 | 71 | 21 | 42.00% |
| Dec 31, 2020 | 50 | 14 | 38.89% |
| Dec 31, 2019 | 36 | 5 | 16.13% |
| Dec 31, 2018 | 31 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Spectral AI | 78 |
| Pieris Pharmaceuticals | 50 |
| GlycoMimetics | 35 |
| Pulmatrix | 22 |
| BriaCell Therapeutics | 16 |
| Cocrystal Pharma | 12 |
| NeuroBo Pharmaceuticals | 8 |
| MIRA Pharmaceuticals | 3 |
ENLV News
- 7 days ago - Enlivex Announces the Dosing of the First Patient in a Phase I Clinical Trial Evaluating Allocetra in Patients with Psoriatic Arthritis - GlobeNewsWire
- 22 days ago - Enlivex Receives Notice of Allowance for Japanese Patent Application Covering the Use of Allocetra™ in Patients with Osteoarthritis - GlobeNewsWire
- 2 months ago - Enlivex Announces Positive DSMB Recommendation to Initiate the Phase II Stage of its Phase I/II Trial of Allocetra in Patients with Moderate to Severe Knee Osteoarthritis - GlobeNewsWire
- 2 months ago - GreenPower and Enlivex Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Accesswire
- 4 months ago - Enlivex Therapeutics and Biotricity Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Accesswire
- 5 months ago - Enlivex Announces Positive Interim Data Readout from a Phase I/II Trial Evaluating Allocetra in End-Stage Knee Osteoarthritis - GlobeNewsWire
- 6 months ago - Enlivex Therapeutics Closes up to $15 Million Registered Direct Offering - GlobeNewsWire
- 6 months ago - Enlivex Therapeutics Announces up to $15 Million Registered Direct Offering - GlobeNewsWire